Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Short term Debt (2020 - 2025)

Cresco Labs (CRLBF) has disclosed Short term Debt for 4 consecutive years, with $11.8 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Short term Debt rose 7.66% year-over-year to $11.8 million, compared with a TTM value of $11.8 million through Dec 2023, up 7.66%, and an annual FY2023 reading of $11.8 million, up 7.66% over the prior year.
  • Short term Debt was $11.8 million for Q4 2023 at Cresco Labs, up from $11.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $25.9 million in Q4 2020 and bottomed at $11.0 million in Q4 2022.
  • Average Short term Debt over 4 years is $17.2 million, with a median of $15.9 million recorded in 2021.
  • The sharpest move saw Short term Debt tumbled 44.92% in 2022, then grew 7.66% in 2023.
  • Year by year, Short term Debt stood at $25.9 million in 2020, then fell by 23.13% to $19.9 million in 2021, then crashed by 44.92% to $11.0 million in 2022, then rose by 7.66% to $11.8 million in 2023.
  • Business Quant data shows Short term Debt for CRLBF at $11.8 million in Q4 2023, $11.0 million in Q4 2022, and $19.9 million in Q4 2021.